Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 4
1949 5
1950 8
1951 7
1952 3
1953 2
1954 1
1955 1
1956 1
1957 3
1958 1
1959 1
1960 2
1961 1
1962 4
1963 5
1964 4
1965 3
1966 2
1967 2
1968 2
1969 2
1970 6
1971 5
1972 1
1973 4
1974 3
1975 6
1976 9
1977 16
1978 10
1979 16
1980 8
1981 12
1982 13
1983 9
1984 14
1985 14
1986 10
1987 13
1988 7
1989 9
1990 13
1991 8
1992 12
1993 7
1994 5
1995 9
1996 5
1997 5
1998 7
1999 4
2000 3
2001 3
2002 1
2003 1
2004 1
2005 2
2006 4
2007 1
2008 1
2011 3
2012 3
2013 3
2014 5
2015 2
2018 1
2019 1
2021 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Results by year

Filters applied: . Clear all
Page 1
Antiseizure Medication-Induced Alopecia: A Literature Review.
Pitton Rissardo J, Fornari Caprara AL, Casares M, Skinner HJ, Hamid U. Pitton Rissardo J, et al. Medicines (Basel). 2023 Jun 9;10(6):35. doi: 10.3390/medicines10060035. Medicines (Basel). 2023. PMID: 37367730 Free PMC article. Review.
Other ASMs associated with alopecia were cenobamate (18), levetiracetam (14), topiramate (13), lacosamide (7), vigabatrin (6), phenobarbital (5), gabapentin (5), phenytoin (4), pregabalin (4), eslicarbazepine (3), brivaracetam (2), clobazam (2), perampanel (2), trimethadione …
Other ASMs associated with alopecia were cenobamate (18), levetiracetam (14), topiramate (13), lacosamide (7), vigabatrin (6), phenobarbital …
Drug-induced myasthenic syndromes.
Kaeser HE. Kaeser HE. Acta Neurol Scand Suppl. 1984;100:39-47. Acta Neurol Scand Suppl. 1984. PMID: 6148832 Review.
An immunological basis for the penicillamine-induced myasthenia gravis is generally approved, but there may be other examples such as trimethadione and phenytoin. The knowledge of these possible side effects is important for the interpretation of unwanted effects, particul …
An immunological basis for the penicillamine-induced myasthenia gravis is generally approved, but there may be other examples such as tri …
Epilepsy and pregnancy.
Morris HH 3rd. Morris HH 3rd. Cleve Clin J Med. 1989;56 Suppl Pt 2:S195-201. doi: 10.3949/ccjm.56.s1.195. Cleve Clin J Med. 1989. PMID: 2659208 Free article. Review.
Since such an adjustment will usually be made in the second or third trimester, one would not expect it to produce an increased number of malformations. Trimethadione should be absolutely avoided and valproic acid used only with caution and with monitoring of alpha fetopro …
Since such an adjustment will usually be made in the second or third trimester, one would not expect it to produce an increased number of ma …
Interactions between calcium and alpha-synuclein in neurodegeneration.
Rcom-H'cheo-Gauthier A, Goodwin J, Pountney DL. Rcom-H'cheo-Gauthier A, et al. Biomolecules. 2014 Aug 14;4(3):795-811. doi: 10.3390/biom4030795. Biomolecules. 2014. PMID: 25256602 Free PMC article. Review.
Ca2+-dependent alpha-syn aggregation could be blocked by the Ca2+ buffering agent, BAPTA-AM, or by the Ca2+ channel blocker, Trimethadione. Furthermore, a greater proportion of cells positive for aggregates occurred when both raised Ca2+ and oxidative stress were combined, …
Ca2+-dependent alpha-syn aggregation could be blocked by the Ca2+ buffering agent, BAPTA-AM, or by the Ca2+ channel blocker, Trimethadion …
Trimethadione as a probe drug to estimate hepatic oxidizing capacity in humans.
Tanaka E, Ishikawa A, Abei M, Kobayashi S. Tanaka E, et al. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1996 Nov;115(3):211-6. doi: 10.1016/s0742-8413(96)00102-8. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1996. PMID: 9375358 Review.
Trimethadione (TMO) has the properties required of probe drugs for the evaluation of hepatic drug-oxidizing capacity in humans in vivo. ...
Trimethadione (TMO) has the properties required of probe drugs for the evaluation of hepatic drug-oxidizing capacity in humans in viv …
Pharmaceutical development for treating pancreatic diseases.
Kitagawa M, Naruse S, Ishiguro H, Hayakawa T. Kitagawa M, et al. Pancreas. 1998 Apr;16(3):427-31. doi: 10.1097/00006676-199804000-00035. Pancreas. 1998. PMID: 9548690 Review.
Extracorporeal shock-wave lithotripsy and oral dissolution therapy with trimethadione are used to treat pancreatic stones. The goals of treatment of acute pancreatitis should be to ameliorate the severity of pancreatic inflammation or to prevent its complications. ...
Extracorporeal shock-wave lithotripsy and oral dissolution therapy with trimethadione are used to treat pancreatic stones. The goals …
Trimethadione (tridione) nephrosis.
ROSENBLUM J, SONNENSCHEIN H, MINSKY AA. ROSENBLUM J, et al. AMA J Dis Child. 1959 Jun;97(6):790-5. doi: 10.1001/archpedi.1959.02070010792005. AMA J Dis Child. 1959. PMID: 13649111 No abstract available.
The fetal trimethadione syndrome.
Zackai EH, Mellman WJ, Neiderer B, Hanson JW. Zackai EH, et al. J Pediatr. 1975 Aug;87(2):280-4. doi: 10.1016/s0022-3476(75)80603-2. J Pediatr. 1975. PMID: 50427
Three families are described in which each of the mothers took trimethadione during pregnancy. From a comparison of siblings in each family and of others exposed to trimethadione in utero, a specific phenotype is delineated. Features included in the fetal trimeth …
Three families are described in which each of the mothers took trimethadione during pregnancy. From a comparison of siblings in each …
Treatment of epilepsy.
BAILEY AA. BAILEY AA. Can Med Assoc J. 1963 Jun 29;88(26):1284-9. Can Med Assoc J. 1963. PMID: 13969008 Free PMC article.
The main clinical types of epilepsy and their treatment are described. The treatment of choice in petit mal epilepsy is trimethadione (Trimedone) 0.3 g., three to six times a day, or acetazolamide (Diamox) 125-250 mg., three to four times a day. ...
The main clinical types of epilepsy and their treatment are described. The treatment of choice in petit mal epilepsy is trimethadione …
Fetal trimethadione syndrome.
Goldman AS, Yaffe SJ. Goldman AS, et al. Teratology. 1978 Feb;17(1):103-5. doi: 10.1002/tera.1420170118. Teratology. 1978. PMID: 625705 No abstract available.
361 results